ENTX - Entera Bio Quarterly EPS earnings growth
Entera Bio Ltd. (ENTX) is driven by its success in developing oral proteins and partnerships with industry behemoths. The quarterly EPS growth marker visualizes the dynamics of these processes, where the indicator value is -58.20. The company's environmental contribution is based on replacing injections with tablets, thereby reducing medical waste. Meanwhile, the strategy relies on patent protection, which offsets current pricing pressure from competitors.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_ENTX_-_Entera-Bio-Ltd._-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "Entera Bio (ENTX): Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 11/12/2026 | 👁️GURU.Markets👁️")
Comprehensive metric breakdowns and analytics for Entera Bio Ltd. (ENTX)
- share price and expert price forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
- earnings and market multiples details:
ENTX - Net Profit|Future Profit Entera Bio Ltd.|ENTX - Company Value to Net Income|Forward P/E Multiple enterabio.com|ENTX - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Entera Bio Corp|ENTX - Operating income before deduction of amortization|Earnings per share for the last twelve months Entera Bio|ENTX - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months enterabio.com|ENTX - Earnings per share increase in current year|Net earnings per share growth forecast for next year Entera Bio Ltd.
Fundamental company valuation:Entera Bio Ltd - ENTX
This indicator measures the quarterly dynamics of net earnings per share, reflecting the actual efficiency of capital management and the business's operational profitability. By analyzing the quarterly EPS growth marker, an investor can identify hidden costs for Entera Bio Ltd. (ENTX) caused by geopolitical instability in Israel, which destabilizes logistics and the execution of clinical trials for pharmaceutical software.
Analysis of competing companies
HLN: Quarterly EPS earnings growth|Kenvue Inc - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma Corp) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Jyong Bio MENS|Year-over-year earnings per share growth for the last twelve months Ligand Pharmaceuticals (LGND)|AMRX (amneal.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth PRGO (Perrigo)|Alvotech S.A. (ALVO) - Earnings per share growth in annualized terms for the last twelve months|LQDA - Year-over-year earnings per share growth for the last twelve months|GLPG (Galapagos Corp) - Year-over-year earnings per share growth for the last 12 months|ANIP (ANI Pharmaceuticals) - Year-over-year net earnings per share growth for the last 12 months|MNKD: Year-over-year earnings per share growth rate for the last twelve months|AMPH (Amphastar Pharmaceuticals, Inc.) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Pacira Pharmaceuticals PCRX|Year-over-year earnings per share growth for the last twelve months ARS Pharma (SPRY)|TBPH (Theravance Corp) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth AQST (Aquestive Therapeutics)|Quarterly EPS earnings growth scPharmaceuticals, Inc. SCPH|TECX: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months TNXP (Tonix Pharma)|SXTC: Quarterly EPS earnings growth|EPRX (Eupraxia Pharmaceuticals Inc.) - Year-over-year earnings per share growth for the last twelve months|BHST (BioHarvest Sciences) - Quarterly EPS earnings growth|invizyne.com (EXOZ) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Oramed Pharmaceuticals (ORMP)|HYFT - Earnings per share growth in annualized terms for the last twelve months|ABVC BioPharma Inc - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months CPIX|QNTM - Year-over-year earnings per share growth for the last twelve months|FGEN: Year-over-year earnings per share growth for the last twelve months|TELO (Telomir Pharmaceuticals, Inc.) - Year-over-year net earnings per share growth for the last 12 months|RANI: Year-over-year earnings per share growth rate for the last twelve months|SNYR (Synergy CHC Corp.) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RLYB (Rallybio Corp.)|Year-over-year net earnings per share growth for the last 12 months LEXX (Lexaria Bioscience)|Year-over-year net earnings per share change for the last twelve months pulmatrix.com|Quarterly EPS earnings growth PTHL (Pheton Holdings)|Aptorum Group Ltd (APM) - Earnings per share growth in annualized terms for the last twelve months|LYRA - Year-over-year earnings per share growth for the last twelve months|IBO (impactbiomedinc.com) - Year-over-year earnings per share growth for the last 12 months|TNFA (tnfpharma.com) - Year-over-year net earnings per share growth for the last 12 months|YCBD: Year-over-year earnings per share growth rate for the last twelve months|Year-over-year net earnings per share growth for the last 12 months PRFX|Year-over-year earnings per share growth for the last 12 months CYTO (Auris Medical)|Year-over-year earnings per share growth for the last twelve months Lipella (LIPO)|OPTN: Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth PIRS (Pieris Pharmaceuticals)|Year-over-year earnings per one share growth for the last 12 months PROC|Petros Pharmaceuticals, Inc. - Quarterly EPS earnings growth|QLI - Quarterly EPS earnings growth|ACELYRIN, Inc. (SLRN) - Year-over-year earnings per share growth for the last twelve months|TFF Pharmaceuticals, Inc - Year-over-year earnings per one share growth for the last 12 months
